Compare NHTC & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NHTC | NOTV |
|---|---|---|
| Founded | 1988 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.3M | 29.9M |
| IPO Year | 1995 | 1997 |
| Metric | NHTC | NOTV |
|---|---|---|
| Price | $2.79 | $0.88 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 79.7K | ★ 1.6M |
| Earning Date | 11-05-2025 | 12-03-2025 |
| Dividend Yield | ★ 28.57% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $40,873,000.00 | ★ $505,299,000.00 |
| Revenue This Year | N/A | $6.11 |
| Revenue Next Year | N/A | $4.69 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 0.85 |
| 52 Week Low | $2.40 | $0.66 |
| 52 Week High | $6.00 | $6.48 |
| Indicator | NHTC | NOTV |
|---|---|---|
| Relative Strength Index (RSI) | 38.48 | 40.49 |
| Support Level | $2.74 | $0.84 |
| Resistance Level | $3.07 | $0.95 |
| Average True Range (ATR) | 0.26 | 0.11 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 19.96 | 53.73 |
Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and to support active, physical and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and rest from China, Taiwan, Japan, United States and other regions.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.